Form 8-K - Current report:
SEC Accession No. 0001437749-26-017082
Filing Date
2026-05-14
Accepted
2026-05-14 16:36:14
Documents
14
Period of Report
2026-05-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tivc20260405_8k.htm   iXBRL 8-K 31145
2 EXHIBIT 99.1 ex_941939.htm EX-99.1 90514
7 logo2.jpg GRAPHIC 6964
  Complete submission text file 0001437749-26-017082.txt   282837

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vbio-20260514.xsd EX-101.SCH 3579
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vbio-20260514_def.xml EX-101.DEF 12187
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE vbio-20260514_lab.xml EX-101.LAB 16396
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vbio-20260514_pre.xml EX-101.PRE 12457
17 EXTRACTED XBRL INSTANCE DOCUMENT tivc20260405_8k_htm.xml XML 3059
Mailing Address 1305 E. HOUSTON STREET BUILDING 1, SUITE 311 SAN ANTONIO TX 78205
Business Address 1305 E. HOUSTON STREET BUILDING 1, SUITE 311 SAN ANTONIO TX 78205 (888)276-6888
Valion Bio, Inc. (Filer) CIK: 0001787740 (see all company filings)

EIN.: 814016391 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41052 | Film No.: 26979739
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 08 Industrial Applications and Services)